# Yeztugo

NDC: 61958-3401
Generic name: LENACAPAVIR SODIUM
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20250618

FDA application: NDA220020

## Active ingredients

- LENACAPAVIR SODIUM: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-3401"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-3401
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c241af1-ce62-4b0a-9eb7-f6b626174f01